Patent Oppositions

Formulating opposition strategy requires in-depth knowledge of the interplay between U.S. and international patent law and global business factors. Oppositions or validity challenges can be filed against patents granted in Europe, Japan, Australia, New Zealand and elsewhere. Sterne Kessler works closely with clients to determine when and where it is well-advised to file an opposition.

As part of a global patent procurement and freedom-to-operate process, we analyze competitors’ patents or applications. As an additional step in this process, we advise clients on putting an opposition or cancellation strategy into play. By having a patent significantly amended or even declared invalid during an opposition/cancellation proceeding, we help clients minimize infringement risk.

Considerations for Foreign Oppositions

  • Cost-effectiveness: The cost of an opposition proceeding in a foreign country is significantly less than U.S. or foreign litigation, promoting their use as a cost-effective offensive tactic.
  • Effect on competitive positions in the United States: Companies often file the same patent application in many foreign countries. Some of our clients have no interest in foreign commercialization of a product, but filing an opposition in Australia, Europe, or elsewhere may help to weaken the competitor’s patent position in the United States.
  • Testing for U.S. enforcement strategy: Arguments in support of amendment and invalidity can be “road-tested” in a foreign jurisdiction before pursuing a similar, more costly strategy in the United States.
  • Influencing competitor’s U.S. enforcement strategy: The defeat of a patent in a foreign country will give a competitor something to consider before engaging in patent litigation in the United States.
  • Effect on U.S. patent prosecution outcomes: Opposition proceedings may be considered material to prosecution in the United States of a related application and would consequently have to be disclosed to the USPTO.
  • Timing of filing: The timing of oppositions filing varies by jurisdiction—for example, in Europe, an opposition must be filed within nine months from the date of publication of the grant of the patent. In Japan, however, trials for invalidation may be filed at any time during the life of the patent.

Related Resources

Firm Announcements

Sterne Kessler and Patterson IP Law Team Up to Secure $12.9M Wirtgen Win Over Caterpillar

Sterne, Kessler, Goldstein & Fox February 27, 2024

In the News

Caterpillar Owes Deere $13 Million in Road-Milling Patent Trial

Bloomberg Law February 27, 2024

In the News

Caterpillar to Pay Wirtgen $12.9M in Damages After Patent Battle

Construction Briefing February 26, 2024

Bylined Articles

Federal Circuit Cases Exploring a Year of Rules, Rulemaking, and Rule Enforcement at the PTAB

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

The Changing Contours of IPR Estoppel Law

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Reexamination Statistics and the Federal Circuit’s SNQ Clarification/Expansion

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Key 2023 PTAB Statistics

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

The Staying Power of Fintiv: The Effect of Parallel Litigation at the PTAB in 2023

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Watch Your Step – Discretionary Denial Under 325(d) Is Alive and Kicking

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 Changes in Director Review

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 PTAB Case Highlights

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 PTAB Year in Review: Editors’ Introduction

Sterne, Kessler, Goldstein & Fox February 8, 2024

Reports

2023 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox February 8, 2024

Press Release

Award-Winning PTAB Team Publishes 2023 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox February 8, 2024

In the News

PTAB Filings Drop Alongside Declining Patent Litigation

Law360 February 7, 2024

Bylined Articles

PTAB: Design Patents for GUI Interface Cancelled in AIA Proceedings

Sterne, Kessler, Goldstein & Fox January 31, 2024

Bylined Articles

An Introduction from the Editor – 2023 Design Patents Year in Review: Analysis and Trends

Sterne, Kessler, Goldstein & Fox January 31, 2024

Reports

2023 Design Patents Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox January 31, 2024

Press Release

Sterne Kessler Publishes 2023 Design Patents Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox January 31, 2024

In the News

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360 January 25, 2024

In the News

Four US patent trends to watch in 2024

Managing IP January 4, 2024

In the News

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal January 3, 2024

Firm Announcements

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox January 3, 2024

In the News

VW To Settle Part Of Cellular Tech Patent Fight With Neo

Law360 December 18, 2023

In the News

These IP Boutique Firms Are Dominating PTAB Work

Law360 May 19, 2022

Speaking Engagement

Which Way Now with the U.S. Patent Office Policies?

November 5, 2021 9:30 AM - 10:15 AM PST

Speaking Engagement

Keeping Up With Developments at the PTAB

November 3, 2021 10:05 AM - 11:05 AM PST

In the News

Uptick in 2020 PTAB Cases May Signal New Normal

Law360 March 10, 2021

Bylined Articles

SEPs In The Wake Of Qualcomm: 4 Defense Issues

Law360 October 31, 2019

PTAB Strategies and Insights

PTAB Strategies and Insights – June 2019

June 19, 2019

Bylined Articles

Supreme Court Eliminates Government as a Party Who Can File AIA Action at PTAB

Sterne, Kessler, Goldstein & Fox P.L.L.C June 19, 2019

Bylined Articles

States Must Face IPR Challenges Similar to Tribes

Sterne, Kessler, Goldstein & Fox P.L.L.C June 19, 2019

Global Patent Prosecution

Global Patent Prosecution Newsletter – June 2019

June 12, 2019

Bylined Articles

A Useful Roadmap for Claiming Cannabis Inventions

Sterne, Kessler, Goldstein & Fox P.L.L.C. June 12, 2019

Press Release

Sterne Kessler Recognized as a “Top Tier” Firm by Legal 500 for Excellence in IP

Sterne, Kessler, Goldstein & Fox June 4, 2019

Press Release

MIP Distinguishes Three Sterne Kessler Directors Among Top 250 Women in IP

Sterne, Kessler, Goldstein & Fox PLLC May 23, 2019

Bylined Articles

Courts Are Filling In Justices’ Design Patent Remedy Void

Law360 April 23, 2019

Webinar

Design Patents: Meeting Obviousness and Novelty Requirements

April 16, 2019 10:00 AM - 10:30 AM PST

Bylined Articles

Biopharma Patent Applicants Should Consider a Rarely Used Strategy

Bloomberg Law March 18, 2019

PTAB Strategies and Insights

PTAB Strategies and Insights – February 2019

February 22, 2019

Bylined Articles

Federal Circuit Issues Further Guidance On AIA Proceeding Standing To Appeal

Sterne, Kessler, Goldstein & Fox P.L.L.C February 22, 2019

Bylined Articles

With The Right Language, Federal Circuit Finds Alternative Invalidity Theories Ok Even Within a Single Ground

Sterne, Kessler, Goldstein & Fox P.L.L.C February 22, 2019

Bylined Articles

Focus2019 #6 – Important Scientific Discovery Does Not Guarantee U.S. Patent Eligibility

Sterne, Kessler, Goldstein & Fox P.L.L.C February 22, 2019

In the News

3 Takeaways From The Latest Ax Of A Diagnostic Patent

Law360 February 12, 2019

In the News

Golf Club Makers Settle Sprawling 23-Patent Suit

Law360 February 4, 2019

In the News

These Firms Scored The Most Patent Work In 2018

Law360 January 31, 2019

In the News

Shutdown Could Disrupt A Number Of ITC Patent Cases

Law360 January 24, 2019

In the News

Fed. Circ. Affirms Toshiba Win Over LCD Screen IP Suit

Law360 January 22, 2019

Bylined Articles

What Cannabis Patent Applicants Can Learn From Biopharma

Law360 January 17, 2019

In the News

3 Takeaways From The PTAB’s Cannabis Experience

Law360 January 11, 2019

PTAB Strategies and Insights

PTAB Strategies and Insights – December 2018

December 27, 2018

Bylined Articles

Proposed New Motion to Amend Procedure Gives Patent Owners a Fighting Chance at Success

Sterne, Kessler, Goldstein & Fox December 27, 2018

Bylined Articles

Federal Circuit Holds No Assignor Estoppel in AIA Proceedings

Sterne, Kessler, Goldstein & Fox December 27, 2018

Bylined Articles

Precedential Opinion Says Rule 36 Creates Collateral Estoppel Despite Its Ambiguous Nature

Sterne, Kessler, Goldstein & Fox December 27, 2018

In the News

The Biggest Patent Cases of 2018

Law360 December 17, 2018

In the News

J&J Tells Fed. Circ. Judge Was Wrong To Nix Zytiga Patent

Law360 December 4, 2018

PTAB Strategies and Insights

PTAB Strategies and Insights – November 2018

November 29, 2018

Bylined Articles

The Growing Influence of Post-Grant Proceedings in Section 337 Investigations

Sterne, Kessler, Goldstein & Fox November 29, 2018

Bylined Articles

Timing is Everything for Discretionary Denial

Sterne, Kessler, Goldstein & Fox November 29, 2018

Bylined Articles

Proposed New Motion to Amend Procedure

Sterne, Kessler, Goldstein & Fox November 29, 2018

Speaking Engagement

Microbiome R&D and Business Collaboration Forum: USA

October 29, 2018 12:00 AM - 11:59 PM PST

In the News

New AIA Plan May Be A Tough Path To Patent Amendments

Law360 October 29, 2018

Bylined Articles

Inventor’s Case Highlights Appeal Option For Rejected Patent

Law360 October 19, 2018

PTAB Strategies and Insights

PTAB Strategies and Insights – October 2018

October 18, 2018

Press Release

IP Powerhouse Sterne, Kessler, Goldstein & Fox Celebrates 40th Anniversary

Sterne, Kessler, Goldstein & Fox October 2, 2018

In the News

Rocket-er Docket: Mass. IP Case Sees 2 Trials In 6 Months

Law360 September 28, 2018

In the News

USPTO Patent-Eligibility Revamp May Face Court Skepticism

Law360 September 25, 2018

Press Release

Sterne Kessler Recognized By LMG Life Sciences Among The Top IP Firms and Attorneys

Sterne, Kessler, Goldstein & Fox September 25, 2018

Bylined Articles

The Latest in Patenting Diagnostic Methods

Bloomberg Law September 24, 2018

PTAB Strategies and Insights

PTAB Strategies and Insights – September 2018

September 21, 2018

Bylined Articles

Statistical Study – PTAB post SAS

Sterne, Kessler, Goldstein & Fox P.L.L.C. September 21, 2018

In the News

No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears

Law360 September 19, 2018

In the News

Are PTAB Appointments Unconstitutional? A Closer Look

Law360 September 5, 2018

In the News

Generics Cos. Urge Fed. Circ. To Upend Depomed Patent Win

Law360 September 4, 2018

In the News

PTAB Again Upholds Cisco Patent On Remand From Fed Circ.

Law360 September 4, 2018

In the News

PTAB Agrees To Review Golf Club Patent Challenges

Law360 August 31, 2018

Bylined Articles

Summary of Trial Practice Guide Updates

Sterne, Kessler, Goldstein & Fox P.L.L.C. August 22, 2018

In the News

Apple, Fitbit Get Heart Sensor Patent Slashed At PTAB

Law360 August 7, 2018

Bylined Articles

The impact of Oil States and SAS on the post-grant landscape

The Patent Lawyer July 31, 2018

Speaking Engagement

MIP PTAB Forum 2018 – West

May 8, 2018

Bylined Articles

The PTAB Gives Section 325(d) Sharp Teeth

Intellectual Property and Technology Law Journal May 7, 2018

Speaking Engagement

MIP PTAB Forum 2018 – East

May 3, 2018

PTAB Strategies and Insights

PTAB Strategies and Insights – April 2018

April 18, 2018

Bylined Articles

Petitioners Face a Heightened ‘Motivation to Combine’ Threshold

Sterne, Kessler, Goldstein & Fox April 18, 2018

Bylined Articles

An Early Obituary for CBM Review

Sterne, Kessler, Goldstein & Fox April 18, 2018

Bylined Articles

Indirectly Related Patents Get Same Claim Construction Through Collateral Estoppel

Sterne, Kessler, Goldstein & Fox April 18, 2018

PTAB Strategies and Insights

PTAB Strategies and Insights – March 2018

March 22, 2018

Bylined Articles

Aqua Appears to be Much Ado About Nothing

Sterne, Kessler, Goldstein & Fox March 21, 2018

Bylined Articles

Patent Owners Should Use Experts to Attack Motivation to Combine at POPR Stage

Sterne, Kessler, Goldstein & Fox March 21, 2018

Bylined Articles

No Second Chance on Remand for Late Arguments

Sterne, Kessler, Goldstein & Fox March 21, 2018

Speaking Engagement

13th Annual Advanced Patent Law Institute

March 1, 2018

Bylined Articles

Indefiniteness is Evolving in Post-Grant Proceedings

Law360 February 20, 2018

In the News

Patent Cases To Watch In 2018

Law360 January 1, 2018

In the News

EA’s Video Game Graphics Patent Challenge Iced By PTAB

Law360 December 27, 2017

PTAB Strategies and Insights

Perspectives on the PTAB Newsletter – December 2017

December 21, 2017

Bylined Articles

The Turning Tide of Adoption of the Lead Compound Analysis Is Favoring Patent Owners at the PTAB

Sterne, Kessler, Goldstein & Fox December 21, 2017

Bylined Articles

The Board Gives Section 325(d) Sharp Teeth—Part III —Things Are Looking Up for Patent Owners

Sterne, Kessler, Goldstein & Fox December 21, 2017

In the News

Prison Phone Rivals Reach Confidential Deal in IP Row

Law360 December 5, 2017

In the News

High Court Split on Forcing Patent Office to Cover All Arguments

Blomberg BNA November 30, 2017

Global Patent Prosecution

Global Patent Prosecution Newsletter – November 2017

November 13, 2017

Bylined Articles

Proposed Emergency Patent Grant Measures in Brazil

Sterne, Kessler, Goldstein & Fox November 13, 2017

Bylined Articles

Statistics on the Backlog Problem and “Fast-Track” Options in Brazil

Sterne, Kessler, Goldstein & Fox November 13, 2017

Bylined Articles

Enforcing Patents in Brazil: An Injunction Paradise?

Sterne, Kessler, Goldstein & Fox November 13, 2017

PTAB Strategies and Insights

Perspectives on the PTAB Newsletter – October 2017

October 18, 2017

Bylined Articles

The Board Gives Section 325(d) Sharp Teeth

Sterne, Kessler, Goldstein & Fox October 18, 2017

Bylined Articles

Second Chances for Secondary Considerations – Hiding the “Novelty Ball”

Sterne, Kessler, Goldstein & Fox October 18, 2017

Bylined Articles

Federal Circuit Reigns in PTAB on Broadest Reasonable Interpretation

Sterne, Kessler, Goldstein & Fox October 18, 2017

In the News

Judge Hacks Away At Allergan’s Restasis Patents

Law360 October 18, 2017

Bylined Articles

Strategies For Protecting Biotechnology In Brazil And China

Law360 October 6, 2017

Bylined Articles

A Survey Of Patent Owner Estoppel At USPTO

Law360 September 26, 2017

Global Patent Prosecution

Global Patent Prosecution Newsletter – September 2017

September 15, 2017

Bylined Articles

Recent Trends on the U.S. Doctrine of Equivalents

Sterne, Kessler, Goldstein & Fox September 15, 2017

Bylined Articles

A Seismic Shift in UK Patent Infringement Law – Actavis v. Eli Lilly

Sterne, Kessler, Goldstein & Fox September 15, 2017

Bylined Articles

Doctrine of Equivalents and Prosecution History Estoppel Around the World

Sterne, Kessler, Goldstein & Fox September 15, 2017

In the News

Global IP Strategies for Procuring and Protecting Green Innovations: A Focus on Europe, Brazil, China, and the US

25th Edition: European Biomass Conference and Exhibition June 12, 2017